Positive News SentimentPositive NewsNASDAQ:LIVN LivaNova (LIVN) Stock Price, News & Analysis $47.45 +0.46 (+0.98%) (As of 09/11/2024 ET) Add Compare Share Share Today's Range$45.93▼$47.5250-Day Range$43.38▼$54.5952-Week Range$42.75▼$64.47Volume429,042 shsAverage Volume659,041 shsMarket Capitalization$2.58 billionP/E RatioN/ADividend YieldN/APrice Target$68.60 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get LivaNova alerts: Email Address LivaNova MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.60 Rating ScoreUpside/Downside44.6% Upside$68.60 Price TargetShort InterestHealthy3.90% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.64Based on 4 Articles This WeekInsider TradingN/AProj. Earnings Growth18.22%From $2.58 to $3.05 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.72 out of 5 starsMedical Sector230th out of 911 stocksElectromedical Equipment Industry5th out of 21 stocks 3.3 Analyst's Opinion Consensus RatingLivaNova has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageLivaNova has only been the subject of 3 research reports in the past 90 days.Read more about LivaNova's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted3.90% of the outstanding shares of LivaNova have been sold short.Short Interest Ratio / Days to CoverLivaNova has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in LivaNova has recently decreased by 11.67%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldLivaNova does not currently pay a dividend.Dividend GrowthLivaNova does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for LIVN. Previous Next 3.7 News and Social Media Coverage News SentimentLivaNova has a news sentiment score of 1.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for LivaNova this week, compared to 3 articles on an average week.Search Interest1 people have searched for LIVN on MarketBeat in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, LivaNova insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.27% of the stock of LivaNova is held by insiders.Percentage Held by Institutions97.64% of the stock of LivaNova is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about LivaNova's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for LivaNova are expected to grow by 18.22% in the coming year, from $2.58 to $3.05 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LivaNova is -79.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of LivaNova is -79.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLivaNova has a P/B Ratio of 2.00. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about LivaNova's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaTrillion Dollar Blockchain Shift Could Trigger THIS CoinIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW About LivaNova Stock (NASDAQ:LIVN)LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.Read More LIVN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LIVN Stock News HeadlinesAugust 29, 2024 | markets.businessinsider.comLivaNova Hold Rating Justified by US VNS Reimbursement Uncertainty and Italian Legal ChallengesAugust 27, 2024 | finance.yahoo.comReturns At LivaNova (NASDAQ:LIVN) Are On The Way UpSeptember 12, 2024 | Deal Maker (Ad)Invest before this deal closes on 9/18This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges as demand ramps up. The market for this type of fuel is projected to grow 1,500% by 2030. Invest before this investment round closes on 9/18.August 22, 2024 | sg.finance.yahoo.comOrthoPediatrics Corp. (KIDS)August 21, 2024 | uk.finance.yahoo.comLivaNova PLC (LIVN)August 5, 2024 | finance.yahoo.comLivaNova PLC (LIA.DU)August 2, 2024 | finance.yahoo.comLivaNova Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsAugust 2, 2024 | msn.comLivaNova PLC (NASDAQ:LIVN) Q2 2024 Earnings Call TranscriptSeptember 12, 2024 | Deal Maker (Ad)Invest before this deal closes on 9/18This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges as demand ramps up. The market for this type of fuel is projected to grow 1,500% by 2030. Invest before this investment round closes on 9/18.July 31, 2024 | markets.businessinsider.comLivaNova’s Strong Performance and Strategic Initiatives Bolster Buy Rating with Increased Price TargetJuly 31, 2024 | seekingalpha.comLivaNova PLC (LIVN) Q2 2024 Earnings Call TranscriptJuly 31, 2024 | finanznachrichten.deLivaNova PLC: LivaNova Reports Second-Quarter 2024 ResultsJuly 31, 2024 | msn.comLivaNova beats Q2 consensus, updates guidanceJuly 31, 2024 | finance.yahoo.comLivaNova Reports Second-Quarter 2024 ResultsJuly 31, 2024 | seekingalpha.comLivaNova PLC 2024 Q2 - Results - Earnings Call PresentationJuly 26, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of LivaNova PLC - LIVNJuly 25, 2024 | nasdaq.comInteresting LIVN Put And Call Options For September 20thJuly 25, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Edwards Lifesciences (EW) and LivaNova (LIVN)See More Headlines Receive LIVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LivaNova and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/01/2024Today9/11/2024Next Earnings (Estimated)11/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNASDAQ:LIVN CUSIPN/A CIK1639691 Webwww.livanova.com Phone442033250660Fax281-218-9332Employees2,900Year FoundedN/APrice Target and Rating Average Stock Price Target$68.60 High Stock Price Target$80.00 Low Stock Price Target$55.00 Potential Upside/Downside+44.6%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($0.60) Trailing P/E RatioN/A Forward P/E Ratio18.39 P/E GrowthN/ANet Income$17.55 million Net Margins-1.37% Pretax Margin-9.00% Return on Equity13.77% Return on Assets7.07% Debt Debt-to-Equity Ratio0.49 Current Ratio3.45 Quick Ratio2.94 Sales & Book Value Annual Sales$1.15 billion Price / Sales2.23 Cash Flow$4.34 per share Price / Cash Flow10.93 Book Value$23.72 per share Price / Book2.00Miscellaneous Outstanding Shares54,300,000Free Float54,006,000Market Cap$2.58 billion OptionableOptionable Beta1.00 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Alex Shvartsburg (Age 53)Chief Financial Officer Comp: $852.2kMs. Trui Hebbelinck (Age 52)Chief Human Resources Officer Comp: $731.41kMr. Vladimir A. Makatsaria (Age 51)CEO & Director Mr. Badri AmurthurChief Technology OfficerLindsey LittleSenior Director of Investor RelationsMr. Michael D. Hutchinson (Age 53)Senior VP, Chief Legal Officer & Company Secretary Deanna WilkeVice President of Corporate CommunicationsMr. Matthew Joseph Dodds IIISenior Vice President of Corporate Development & ITDr. Bryan D. Olin Ph.D. (Age 57)Senior VP & Head of Product Development - Neuromodulation Mr. Ryan MillerPresident of Advanced Circulatory SupportMore ExecutivesKey CompetitorsHaemoneticsNYSE:HAENatus MedicalNASDAQ:NTUSOutset MedicalNASDAQ:OMMasimoNASDAQ:MASIPenumbraNYSE:PENView All CompetitorsInsiders & InstitutionsDriehaus Capital Management LLCBought 213,749 shares on 8/16/2024Ownership: 1.005%Perceptive Advisors LLCBought 145,000 shares on 8/16/2024Ownership: 0.820%AQR Capital Management LLCBought 930 shares on 8/15/2024Ownership: 0.240%Millennium Management LLCBought 10,400 shares on 8/15/2024Ownership: 0.000%Point72 Asia Singapore Pte. Ltd.Sold 1,952 shares on 8/15/2024Ownership: 0.003%View All Insider TransactionsView All Institutional Transactions LIVN Stock Analysis - Frequently Asked Questions How have LIVN shares performed this year? LivaNova's stock was trading at $51.74 at the beginning of 2024. Since then, LIVN stock has decreased by 8.3% and is now trading at $47.45. View the best growth stocks for 2024 here. How were LivaNova's earnings last quarter? LivaNova PLC (NASDAQ:LIVN) released its quarterly earnings data on Wednesday, May, 1st. The company reported $0.73 EPS for the quarter, beating analysts' consensus estimates of $0.45 by $0.28. The company's revenue for the quarter was up 12.0% compared to the same quarter last year. What is Damien McDonald's approval rating as LivaNova's CEO? 47 employees have rated LivaNova Chief Executive Officer Damien McDonald on Glassdoor.com. Damien McDonald has an approval rating of 77% among the company's employees. Who are LivaNova's major shareholders? Top institutional shareholders of LivaNova include Primecap Management Co. CA (11.05%), Dimensional Fund Advisors LP (2.49%), Barrow Hanley Mewhinney & Strauss LLC (2.39%) and Point72 Asset Management L.P. (2.37%). Insiders that own company stock include Damien Mcdonald, Daniel Jeffrey Moore and Alfred J Novak. View institutional ownership trends. How do I buy shares of LivaNova? Shares of LIVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of LivaNova own? Based on aggregate information from My MarketBeat watchlists, some other companies that LivaNova investors own include BioTelemetry (BEAT), Occidental Petroleum (OXY), Pfizer (PFE), Amarin (AMRN), Genocea Biosciences (GNCA), AbbVie (ABBV) and Abbott Laboratories (ABT). This page (NASDAQ:LIVN) was last updated on 9/12/2024 by MarketBeat.com Staff From Our PartnersInvest before this deal closes on 9/18This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges ...Deal Maker | Sponsored“Why I don’t care if the Fed cuts rates” - SYKES In on Friday out by Monday Over the past decade I’ve made millions of dollars with a strategy I call Weeken...Timothy Sykes | SponsoredHow you could collect “AI Royalties” from NVIDIA, META and TSMC...If you've missed out on the first wave of big AI winners... Don't worry. Because there's a much better -...Behind the Markets | SponsoredRecently listed NASDAQ firm is well positioned for growth with game-changing AI platform for e-commerce.With an innovative AI platform, one tiny but growing NASDAQ firm is ushering in a new e-commerce era and is tr...Smallcaps Daily | SponsoredPlace this $0.99 trade BEFORE the electionEarlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands o...Monument Traders Alliance | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LivaNova PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share LivaNova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
